FDA Peptide Update: Category 2 Removals Explained The peptide conversation is shifting. Secretary RFK Jr. recently announced that the FDA plans to move 14 peptides from Category 2 back to Category 1 restoring FDA recognized status and making them When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions FDA July 2026 Peptide Meeting: What Patients Need to Know About Access, Approval, and Safety Meto blog What Peptides Are Legal in the U.S.? Understanding FDA Approval, Compounding, and the Legal Gray Areas